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Abstract. In this paper, we consider an improved Human T-lymphotropic virus type I (HTLV-I)
infection model with the mitosis of CD4+ T cells and delayed cytotoxic T-lymphocyte (CTL)
immune response by analyzing the distributions of roots of the corresponding characteristic
equations, the local stability of the infection-free equilibrium, the immunity-inactivated equilibrium,
and the immunity-activated equilibrium when the CTL immune delay is zero is established. And
we discuss the existence of Hopf bifurcation at the immunity-activated equilibrium. We define the
immune-inactivated reproduction ratio R0 and the immune-activated reproduction ratio R1. By
using Lyapunov functionals and LaSalle’s invariance principle, it is shown that if R0 < 1, the
infection-free equilibrium is globally asymptotically stable; if R1 < 1 < R0, the immunity-
inactivated equilibrium is globally asymptotically stable; if R1 > 1, the immunity-activated
equilibrium is globally asymptotically stable when the CTL immune delay is zero. Besides, uniform
persistence is obtained when R1 > 1. Numerical simulations are carried out to illustrate the
theoretical results.
Keywords: HTLV-I infection, the mitosis of CD4+ T cells, delayed CTL immune response, the
reproduction ratio, Lyapunov functionals, Hopf bifurcation.
1 Introduction
Human T-lymphotropic virus type I (HTLV-I) is a pathogenic retrovirus. About 10 million
to 20 million people worldwide are infected [1, 13, 19]. It is closely linked to two main
types of viral diseases: adult T cell leukaemia/lymphoma (ATL), an aggressive blood can-
cer; and HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP), a pro-
gressive neurological and inflammatory disease [8,9,20,21]. However, there is no definite
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mechanism for the development of HTLV-I related diseases and no effective treatment.
Besides, most of the infected persons are asymptomatic carriers, and only 0.1–4 % of
the infected persons develop from long-term asymptomatic carriers to ATL or HAM/TSP
[21].
Similar to Human Immunodeficiency Virus (HIV), the target cell of HTLV-I is CD4+
T cells. For the infected CD4+ T cells, a hypothesis was put forward by Asquith and
Bangbam that only a small part of infected CD4+ cells express Tax [5]. Based on this, the
infected CD4+ T cells were divided into actively infected CD4+ T cells and latently in-
fected CD4+ T cells according to whether Tax is expressed or not [5]. And the hypothesis
of dynamic interaction between CD4+ T cells without Tax expression and CD4+ T cells
with Tax expression proposed by Asquith and Bangbam explains that HTLV-I infected
individuals have a sustained activation of the specific immune response to HTLV-I, while
the viral load increases [3]. Therefore, it is very important to distinguish latently infected
CD4+ T cells from actively infected CD4+ T cells. For mitosis, it should be pointed
out that although mitosis is a natural process that occurs in all CD4+ T cells, normal
homeostatic mitosis occurs at a much slower rate than that of actively infected CD4+
T cells proliferation. To avoid unnecessarily complicating the mathematical analysis, the
mitosis of the healthy and latently CD4+ T cells is ignored [15].
Based on the above discussion, in order to explore the dynamic interaction between
latently infected CD4+ T cells and actively infected CD4+ T cells in HTLV-I infection,
in [15], Lim and Li proposed the following mathematical model:
x′(t) = λ− dx− βxy,






y′(t) = σu− ay,
(1)
where x(t) denotes the concentration of healthy CD4+ T cells, which are produced at
rate λ and die at rate d, u(t) denotes the concentration of latently infected CD4+ T cells,
and y(t) denotes the concentration of actively infected CD4+ T cells; β is the transmission
coefficient; a and µ represent the death rates of actively infected CD4+ T cells and latently
infected CD4+ T cells, respectively; σ is the rate at which latently infected CD4+ T cells
translate into actively infected CD4+ T cells. δβxy and εry(1 − (x + u)/k) are used
to describe the newly infected CD4+ T cells entering the latently infected CD4+ T cells
compartment through infection and mitosis or vertical transmission, respectively.
In model (1), logistic growth term ry(1−(x+u)/k) is used to describe the mitosis
of actively infected CD4+ T cells. However, the numerical results show that there is no
qualitative difference between exponential growth term and logical growth term in the
behaviour of trajectories [17]. Therefore, in order to avoid the complication of the model
equation, it is reasonable to assume that x(t)+u(t)k, the proliferation of actively infec-
ted CD4+ T cells follows an exponential growth term ry instead of logical growth term
ry(1−(x+u)/k). The exponential growth term ry has been used by Lim and Maini [17].
In the process of HTLV-I infection, a strong cytotoxic T lymphocyte (CTL) immune
response was established to fight infection [5, 12]. In the most virus infections, CTL
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immune response can lower the proviral load and consequently lower the risk of disease
[1]. However, experiments have shown that the cytotoxicity of CTL ultimately leads to
demyelination of HAM/TSP central nervous system and the development of HAM/TSP
disease [16]. It can be seen that the effect of CTL immune response on HTLV-I infection
is much more complicated. Therefore, the consideration of CTL immune response in
the HTLV-I infection model is of great significance to the study of the development and
treatment of ATL or HAM/TSP.
Since antigenic stimulation to generate HTLV-I specific CTLs involves a series of
events that require a time delay [7]. Therefore, it is necessary to consider the effect of
time delay in the model, and the form of CTL immune function f(y, z) = cy(t − τ) has
been used in [14]. Motivated by the works of Li and Shu [16], Lim and Maini [17], in this
paper, we consider the following HTLV-I infection model with actively infected CD4+
T cells mitosis and delayed CTL immune response:
x′(t) = λ− dx− βxy,
u′(t) = βxy + ry − (µ+ σ)u,
y′(t) = σu− ay − pyz,
z′(t) = cy(t− τ)z(t− τ)− bz,
(2)
where z(t) denotes the concentration of the specific CD8+ CTLs, b is the death rate
of specific CD8+ CTLs; pyz describes actively infected CD4+ T cells being lysed by
specific CD8+ CTLs, cy(t − τ)z(t − τ) represents that the CTLs produced at time t
depends on the concentration of CTLs and actively infected CD4+ T cells at time t − τ
[16, 23]. Experiments have shown that the mitosis of actively CD4+ T cells is usually
lower than the removal rate caused by natural death [17], hence, in the following, we
assume that a > r.
The initial condition for system (2) takes the form
x(θ) = φ1(θ), u(θ) = φ2(θ), y(θ) = φ3(θ), z(θ) = φ4(θ),
φi(θ) > 0, θ ∈ [−τ, 0), φi(0) > 0 (i = 1, 2, 3, 4),
(3)
where (φ1(θ), φ2(θ), φ3(θ), φ4(θ)) ∈ C([−τ, 0],R4+0), here R4+0 = {(x1, x2, x3, x4):
xi > 0, i = 1, 2, 3, 4}.
This paper is organized as follows. In Section 2, we show the positivity and bound-
edness of solutions to system (2). In Section 3, the existence of feasible equilibria, the
local stability of the infection-free equilibrium, the immunity-inactivated equilibrium,
and the immunity-activated equilibrium (when τ = 0) is established. And we discuss
the existence of Hopf bifurcation at the immunity-activated equilibrium. In Section 4,
by constructing suitable Lyapunov functionals and using LaSalle’s invariance principle,
the global stability of the infection-free equilibrium, the immune-inactivated equilibrium,
and the immune-activated equilibrium (when τ = 0) is established. In Section 5, we
analyze the uniform persistence of system (2) when the immune-activated reproduction
ratio is greater than one. In Section 6, we give some numerical simulations to illustrate
the theoretical results. Finally, a brief remark is given in Section 7 to conclude this work.
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2 The positivity and boundedness of solutions
Theorem 1. Any solution of system (2) with the initial condition (3) is defined on [0,+∞)
and remains positive for all t > 0.
Proof. Let (x(t), u(t), y(t), z(t)) be any solution of system (2) with the initial condi-
tion (3). First, by the first equation of system (2) we have ẋ|x=0 = λ > 0. This implies
that x(t) > 0 for all t > 0 as long as x(0) = φ1(0) > 0.
Next, we show that u(t) > 0 for all t > 0. Notice that u0 = φ2(0) > 0 if there
exists a t0 such that u(t0) = 0, then t0 > 0. Assume that t0 is the first time such that
u(t) = 0, that is, t0 = inf{t > 0: u(t0) = 0}. Then u̇(t0) = (βx(t0) + r)y(t0) 6 0.















Thus, we have y(t0) > 0. The contradiction shows that u(t) > 0 for all t > 0. Similarly,
we can obtain y(t) > 0 for all t > 0.






y(s− τ)z(s− τ)ebs ds
)
e−bt.
When t ∈ [0, τ), we have z(t − τ) = φ4(t − τ) > 0. Hence, according to (2), we have
z(t) > 0 for t ∈ [0, τ). Similarly, when t ∈ [τ, 2τ), we can obtain that z(t) > 0. By
using mathematical induction method we have z(t) > 0 for all t > 0. This completes the
proof.
Theorem 2. There is a positive constantM such that for any positive solution (x(t), u(t),
y(t), z(t)) of system (2) with the initial condition (3),
lim sup
t→+∞





y(t) < M, lim sup
t→+∞
z(t) < M.
Proof. Let (x(t), u(t), y(t), z(t)) be any positive solution of system (2) with the initial
condition (3). Define




Calculating the derivative of N(t) along positive solution of system (2), it follows that




yielding lim supt→+∞N(t) 6 λ/m, where m = min{d, µ, a− r, b}.
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Therefore, the following set is positively invariant for system (2):
Ω =
{








If we choose M = (λ/m) min{1, c/p}, then Theorem 2 follows.
3 Equilibria, local stability, and Hopf bifurcation
In this section, we study the existence of feasible equilibria, the local stability of the
infection-free equilibrium, the immunity-inactivated equilibrium, and the immunity-acti-
vated equilibrium (when τ = 0) of system (2) by analyzing the distributions of roots of
the corresponding characteristic equations, and we show the existence of Hopf bifurcation
at the immunity-activated equilibrium.
System (2) always has an infection-free equilibrium E0(λ/d, 0, 0, 0). We can obtain










where ρ(FV −1) is the spectrum radius of FV −1. R0 represents the expected number
of newly infected cells generated by a single infected cell in its life span. If R0 > 1,
in addition to the infection-free equilibrium, system (2) has an immunity-inactivated

















If R1 > 1, in addition to E0 and E1, system (2) has an immunity-activated equilibrium















Theorem 3. If R0 < 1, the infection-free equilibrium E0 of system (2) is locally asymp-
totically stable; if R0 > 1, E0 is unstable.
Proof. The characteristic equation of system (2) at the equilibrium E0 is
(s+ b)(s+ d)
[
s2 + (a+ µ+ σ)s+ (1−R0)
]
= 0. (4)
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Clearly, (4) has negative real roots s1 = −b, s2 = −d, and other roots of (4) are
determined by the following equation:
f(s) := s2 + (a+ µ+ σ)s+ (1−R0) = 0. (5)
If R0 < 1, it is easy to show that all roots of (5) have only negative real parts.
Therefore, the equilibrium E0 is locally asymptotically stable.
If R0 > 1, we have f(0) < 0, f(s) → +∞ (s → +∞). Hence, (5) has at least one
positive real root. Accordingly, E0 is unstable.
Theorem 4. If R1 < 1 < R0, the immunity-inactivated equilibrium E1 of system (2) is
locally asymptotically stable; if R1 > 1, E1 is unstable.
Proof. The characteristic equation of system (2) at the equilibrium E1 is
g(s)h(s) = 0, (6)
where
g(s) = s+ b− cy1e−sτ ,














We first claim that all roots of the following transcendental equation
s+ b− cy1e−sτ = 0 (7)
have negative real parts. Otherwise, there exists a root s1 = a1 + ib1 with a1 > 0. If
R1 < 1 < R0, we have
|s1 + b| > b,
∣∣cy1e−sτ ∣∣ 6 |cy1| < b.
It follows that
|s1 + b| >
∣∣cy1e−s1τ ∣∣,
which contradicts (7). Hence, all roots of (7) have negative real parts, and other roots
















Now, we claim that all roots of (8) have negative real parts. Otherwise, there exists a root
s2 = a2 + ib2 with a2 > 0. In this case, we have∣∣∣∣ s2µ+ σ + 1
∣∣∣∣ > 1, ∣∣∣∣s2a + 1
∣∣∣∣ > 1, ∣∣∣∣βy1∣∣∣∣ > ∣∣∣∣βy1 rσa(µ+ σ)
∣∣∣∣.
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∣∣∣∣(s2 + d+ βy1) + βy1rσa(µ+ σ)
∣∣∣∣,
which contradicts (8). Therefore, ifR1 < 1 < R0, all roots of (8) have negative real parts.
Further, all roots of (6) have negative real parts. Accordingly, E1 is locally asymptotically
stable.
If R1 > 1, it only needs to consider (7), it is clear that g(0) = b − cy1 < 0, g(s) =
s + b − cy1e−sτ → +∞ (s → +∞). Therefore, (6) has at least one positive real root.
Accordingly, E1 is unstable.
The characteristic equation of system (2) at the immunity-activated equilibrium E∗ is
s4 + p3s
3 + p2s




2 + q1s+ q0
)




p1 = b(d+ βy
∗)(a+ pz∗ + µ+ σ) + β2x∗y∗σ,
p2 = (d+ βy
∗)(a+ pz∗ + b+ µ+ σ) + b(a+ pz∗ + µ+ σ),
p3 = a+ pz
∗ + d+ βy∗ + b+ µ+ σ,
q0 = −b
[





(µ+ σ)(d+ βy∗) + (a+ pz∗)(d+ βy∗)− pz∗(µ+ σ + d+ βy∗)
]
,
q2 = −b(a+ d+ βy∗ + µ+ σ),
q3 = −b.
When τ = 0, (9) reduces to
s(s+ d+ βy∗)(s+ µ+ σ)(s+ a+ pz∗) + sβ2x∗y∗σ
+ (s+ d+ βy∗)(s+ µ+ σ)pbz∗
= s(s+ d+ βy∗)(a+ pz∗)(µ+ σ). (10)
Now, we claim that all roots of (10) have negative real parts. Otherwise, (10) has at least
one root s1 = x1 + iy1 with x1 > 0. Noting that∣∣s1(s1 + d+ βy∗)(s1 + µ+ σ)(s1 + a+ pz∗) + s1β2x∗y∗σ
+ (s1 + d+ βy
∗)(s1 + µ+ σ)pbz
∗∣∣
>
∣∣s1(s1 + d+ βy∗)(a+ pz∗)(µ+ σ)∣∣,
which contradicts (10). Thus, all roots of (10) have negative real parts. Hence, when
τ = 0, the equilibrium E∗ is locally asymptotically stable.
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When τ > 0, substituting s = iω (ω > 0) into (9) and separating real and imaginary
parts, we have
ω4 − p2ω2 + p0 = (q3ω3 − q1ω) sinωτ + (q2ω2 − q0) cosωτ,
p3ω
3 − p1ω = (q2ω2 − q0) sinωτ − (q3ω3 − q1ω) cosωτ.
(11)








0 − q20 , C1 = p21 − 2p0p2 − q21 + 2q0q2,
C2 = p
2
2 + 2p0 − 2p1p3 + 2q1q3 − q22 , C3 = p23 − 2p2 − q23 .
Let z = ω2. Equation (12) becomes
h(z) := z4 + C3z
3 + C2z
2 + C1z + C0 = 0. (13)
Clearly, if C0 < 0, we have h(0) = C0 < 0, limz→+∞ h(z) = +∞.
Therefore, (13) has at least one positive root. From (13) we have
h′(z) = 4z3 + 3C3z























































+ 2 Re{α}, −C1
4




if D0 < 0,
where α is one of cubic roots of the complex numberQ/2+
√
D0, and ε = −1/2+
√
3/2i.
By [27] we have the following result.
Lemma 1. (See [27].)
(i) If C0 < 0, then (13) has at least one positive root.
(ii) Assume that C0 > 0, then (13) has no positive roots if one of the following
conditions holds:
(a) D0 > 0 and z∗1 < 0;
(b) D0 = 0 and z∗2 < 0;
(c) D0 < 0 and z∗3 < 0.
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(iii) Assume thatC0 > 0, then (13) has at least one positive root if one of the following
conditions holds:
(a) D0 > 0, z∗1 > 0, and h(z
∗
1) < 0;
(b) D0 = 0, z∗2 > 0, and h(z
∗
2) < 0;
(c) D0 < 0, z∗3 > 0, and h(z
∗
3) < 0.
Without loss of generality, we assume that (13) has positive real roots zk (k = 1, 2,
. . . , k̄), where 1 6 k̄ 6 4. Then (12) has positive roots ωk =
√
zk (k = 1, 2, . . . , k̄).













where k = 1, 2, . . . , k̄, j = 1, 2, . . . . Then ±ωk is a pair of purely imaginary roots of
(12) with τ = τ (j)k .
Denote τ0 = mink∈{1,2,...,k̄}{τ
(0)
k }, ω0 = ωk0. Let s(τ) = ψ(τ) + iω(τ) be a root
of (9) satisfying ψ(τ (j)k ) = 0, ω(τ
(j)





3 + 3s2p3 + 2sp2 + p1)
s(s4 + p3s3 + p2s2 + p1s+ p0)
+
3q3s
2 + 2q2s+ q1













(q3ω20 − q1)2 + (q0 − q2ω20)2
.
From what has been discussed above we have the following result [22, 26].
Theorem 5. For system (2), we have
(i) If Eq. (13) has no positive roots, then the equilibriumE∗ is locally asymptotically
stable.
(ii) If Eq. (13) has at least one positive root, and h′(ω20) 6= 0, then the equilibriumE∗
is locally asymptotically stable for τ ∈ [0, τ0) and unstable for τ > τ0. Further,
system (2) undergoes a Hopf bifurcation at E∗ when τ = τ0.
4 Global stability
In this section, we study the global stability of the infection-free equilibrium, the immune-
inactivated equilibrium, and the immune-activated equilibrium (when τ = 0) of sys-
tem (2) by using Lyapunov functionals and LaSalle’s invariance principle.
Theorem 6. If R0 < 1, the infection-free equilibrium E0(x0, 0, 0, 0) of system (2) is
globally asymptotically stable.
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Proof. Let (x(t), u(t), y(t), z(t)) be any positive solution of system (2) with the initial
condition (3). Define























(λ− dx) + βx0y + ry −
µ+ σ
σ










+ r − a(µ+ σ)
σ
)













It follows that Ẇ0(t) 6 0, Ẇ0(t) = 0 if and only if x = x0, u = 0, y = 0, z = 0. The
maximal variant set in {(x(t), u(t), y(t), z(t)) ∈ Ω: Ẇ0(t) = 0} is the singleton {E0}.
From Theorem 3, E0 is locally asymptotically stable. Accordingly, the global stability
of E0 follows from LaSalle’s invariance principle.
Theorem 7. If R1 < 1 < R0, the immunity-inactivated equilibrium E1(x1, u1, y1, 0) of
system (2) is globally asymptotically stable.
Proof. Let (x(t), u(t), y(t), z(t)) be any positive solutions of system (2) with the initial
condition (3). Define
W1(t) = x(t)− x1 − x1 ln
x(t)
x1



























− dx+ dx1 + βx1y + ry − (βxy + ry)
u1
u
+ (µ+ σ)u1 −
a(µ+ σ)
σ
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On substituting
λ = dx1 + βx1y1, βx1y1 + ry1 = (µ+ σ)u1, σu1 = ay1














+ βx1y1 + ry1



















































It follows from x(t) = x1 that ẋ(t) = 0. According to the first equation of system (2),
we have
0 = ẋ(t) = λ− dx1 − βx1y(t),
which yields y(t) = y1. In addition, according to (4), we have u(t) = u1. Hence,
Ẇ1(t) = 0 if and only if x = x1, u = u1, y = y1, z = 0. Hence, the maximal variant
set in {(x(t), u(t), y(t), z(t)) ∈ Ω: Ẇ1(t) = 0} is the singleton {E1}. Note that E1 is
locally asymptotically stable. From LaSalle’s invariance principle we conclude that E1 is
globally asymptotically stable.
Theorem 8. If R1 > 1, the immunity-activated equilibrium E∗(x∗, u∗, y∗, z∗) of sys-
tem (2) is globally asymptotically stable when τ = 0.
Proof. Let (x(t), u(t), y(t), z(t)) be any positive solution of system (2) with the initial
condition (3). Define
W2(t) = x(t)− x∗ − x∗ ln
x(t)
x∗















































(cyz − bz). (16)
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On substituting
λ = dx∗ + βx∗y∗, βx∗y∗ + ry∗ = (µ+ σ)u∗,
σu∗ = ay∗ − py∗z∗, cy∗ = b

























































































It follows from x(t) = x∗ that ẋ(t) = 0. According to the first equation of system (2),
we have
0 = ẋ(t) = λ− dx∗ − βx∗y(t),
which yields y(t) = y∗. In addition, according to (4), we have u(t) = u∗. Furthermore,
we have z(t) = z∗. Hence, we have Ẇ2(t) = 0 if and only if x = x∗, u = u∗, y = y∗,
z = z∗. Hence, the maximal variant set in {(x(t), u(t), y(t), z(t)) ∈ Ω: Ẇ2(t) = 0}
is the singleton {E∗}. Noting that E∗ is locally asymptotically stable. From LaSalle’s
invariance principle we see that E∗ is globally asymptotically stable when τ = 0.
5 Uniform persistence
In this section, we verify the uniform persistence of system (2) when R1 > 1.
Assume that T (t) is a C0 semigroup of X satisfying
T (t) : X0 → X0, X0 → X0. (17)
Let T∂(t) = T (t)|X0 , A∂ be the global attractor for T∂(t). The following results was
developed in [10].
Lemma 2. (See [10].) Suppose that T (t) satisfies (17) and that the following conditions
are valid:
http://www.journals.vu.lt/nonlinear-analysis
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(i) There is a t0 > 0 such that T (t) is compact for t > t0.
(ii) T (t) is point dissipative in X .
(iii) Ã∂ = ∪ω(x) (x ∈ A∂) is isolated and has an acyclic covering M̃ , where M̃ =
{M1,M2, . . . ,Mn}.
(iv) W s(Mi) ∩X0 = φ, i = 1, 2, . . . , n.




d(T (t)x,X0) > ε,
where d is the distance of T (t)x from X0.
Theorem 9. If R1 > 1, system (2) is uniformly persistent.
Proof. Let X = R4+, X0 = U1 ∪ U2, where U1 = {(x, u, y, z) ∈ R4+: u ≡ 0, y ≡ 0},
U2 = {(x, u, y, z) ∈ R4+: z ≡ 0}. Let X0 = X \X0, where X0 is a positive invariant set
for system (2), X0 is a positive invariant set for system (2) when any initial component is
zero. Therefore, X satisfies (17). Denote
φ0 =
(





x(t), u(t), y(t), z(t)
)
(t > 0),
where (x(t), u(t), y(t), z(t)) is a positive solution of system (2) with the initial condi-
tion (3). Then {T (t)}t>0 is a C0 semigroup generated by (2). It is easy to prove that
conditions (i)–(iv) of Lemma 2 is satisfied when R1 > 1. Therefore, all solutions of
system (2) in X0 are uniform repellers with respect to X0 [25]. In other words, there is
an ε0 > 0 such that for any solution Φ(t) := (x(t), u(t), y(t), z(t)) of system (2) with














> ε1, lim inf
t→+∞
z(t) > ε1
for any solution of system (2) with the initial condition in X0. We obtain from the first
equation of system (2) that
x′ = λ− dx− βxy > λ− (d+ βM)x.
By comparison we have x(t) > λ/2(d+ βM) for sufficiently large t, for any solution of
system (2) with initial condition in X0.
Let y∞ = lim inft→+∞ y(t), u∞ = lim inft→+∞ u(t). By the fluctuations lemma
in [11] there exists a sequence τn → ∞, y(τn) → y∞ and y′(τn) = 0. By the third
equation of system (2) we have
0 = σ lim
n→∞
u(τn)− ay∞ − py∞ lim
n→∞
z(τn),
Nonlinear Anal. Model. Control, 26(1):1–20




y∞ + y∞ > u∞ + y∞ > ε1.
Therefore, y∞ > ε1σ/(a+ pM + σ). Similarly, there exists a sequence τn → ∞,
u(τn)→ u∞ and u′(τn) = 0. Then by the second equation of system (2) we have
(µ+ σ)u∞ = β lim
n→∞













2(d+ βM)(a+ pM + σ)(µ+ σ)
:= ε2.
Let ε = min{λ/(d+ βM), ε2, ε1σ/(a+ pM + σ), ε1}. We have
lim inf
t→+∞





y(t) > ε, lim inf
t→+∞
z(t) > ε,
for any solution of system (2) with the initial condition in X0. Hence, system (2) is
uniformly persistent.
6 Numerical simulation
In this section, we carry out numerical simulations to illustrate our analytical results.
The relevant parameters are listed in Table 1. Here, we choose the initial condition as
(850, 1, 0.5, 1) [6].
We choose λ = 1, β = 0.001, r = 0.02, σ = 0.003, p = 0.029, a = µ = d = 0.03,
c = 0.036, b = 0.04. By calculation we obtain that R0 = 10/93 < 1. System (2) has
an infection-free equilibrium E0(100/3, 0, 0, 0). From Theorem 3 the equilibrium E0 is
locally asymptotically stable (see Fig. 1).
Table 1. Table of biologically relevant parameter ranges (values).
Parameter Value Biological meaning Ref.
λ 1–10 Rate of production of healthy cells [14]
β 0.001 Infectious transmissibility coefficient [14]
d 0.01–0.11 Natural death rate of healthy cells [14]
r 0.01–0.045 Proliferation rate of actively infected cells [4]
µ 0.01–0.11 Natural death rate of latently infected cells [14]
σ 0.0003–0.03 Rate of spontaneous Tax expression [15]
a 0.01–0.11 Natural death rate of actively infected cells [14]
p 0.007–0.220 Rate of CTL lysis of actively infected cells [4]
c 0.009–0.16 Proliferation rate of CTLs [2]
b 0.03–0.05 Natural death rate of virus-specific CTLs [14]
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Figure 1. When R0 < 1, E0(100/3, 0, 0, 0) is locally asymptotically stable.








































Figure 2. When R1 < 1 < R0, E1(30, 40/3, 40/3, 0) is locally asymptotically stable.
We choose λ = 1, d = 0.01, β = 0.001, r = 0.03, µ = σ = 0.03, a = 0.06,
p = 0.029, c = 0.036, b = 0.05. It is easy to show R1 = 161/164 < 1 < 10/9 =
R0. System (2) has an immunity-inactivated equilibrium E1(90, 20/9, 10/9, 0). From
Theorem 4 the equilibrium E1 is locally asymptotically stable. Numerical simulation
illustrates this fact (see Fig. 2).
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Figure 3. When R1 > 1, τ = 0.2 < τ0, E∗(90, 110/54, 10/9, 25/29) is locally asymptotically stable.









































Figure 4. When R1 > 1, τ = 8.5 > τ0, E∗(90, 110/54, 10/9, 25/29) is unstable.
We choose λ = 1, β = 0.001, r = 0.02, d = 0.01, p = 0.029, a = σ = µ = 0.03,
c = 0.036, b = 0.04. It is easy to show R1 = 11/6 > 1. System (2) has an immunity-
activated equilibriumE∗(90, 110/54, 10/9, 25/29). From Theorem 5 the equilibriumE∗
is locally asymptotically stable when τ < τ0, E∗ is unstable when τ > τ0. Numerical
simulation illustrates this fact (see Figs. 3 and 4).
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(d) R1 > 1, τ = 8.5 > τ0
Figure 5. Phase trajectory of the feasible equilibria of system (2).
In order to see the behavior of the solution of system (2), we obtain the phase trajectory
of the feasible equilibria of system (2) (see Fig. 5). From Figs. 5(a) and 5(b) we see that
the infection-free equilibriumE0 and the immunity-inactivated equilibriumE1 are locally
asymptotically stable for any τ > 0. Besides, the immunity-activated equilibrium E∗ is
locally asymptotically stable when τ < τ0, a periodic oscillation exists when τ > τ0
(see Figs. 5(c) and 5(d)). Besides, we obtain the bifurcation diagram of system (2) (see
Fig. 6).
LHS allows an un-biased estimate for each parameter of R0 and R1, a probability
density function is defined and divided into N equal probability intervals. N represents
the sample size. The choice for N should be at least k + 1, where k is the parameters
varied, but usually much larger to ensure accuracy. A single value is then selected ran-
domly from every interval [18]. In this way, an input value from each sampling interval is
used only once in the analysis, but the entire parameter space is equitably sampled in an
efficient manner.
Through analysis of the sample derived from LHS, we can obtain large efficient data
in respect to different parameters ofR0 andR1. Figure 7 shows that r, σ are both positive
correlative variables with R0 and R1. It is clear that σ contributes more to R0 and R1
than r, hence, σ is a more important factor.
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Figure 6. The bifurcation diagram of system (2) plotted for increasing values of the time delay.
Figure 7. Tornado plot of partial rank correlation coefficients in respect to R0, R1.
7 Conclusions
In this paper, we considered an improved HTLV-I infection model with CD4+ T cells
mitosis and delayed cytotoxic T-lymphocyte (CTL) immune response. Through a rigorous
mathematical analysis, the threshold dynamical of the model was established, and it can
be determined by the immune-inactivated reproduction ratioR0 and the immune-activated
reproduction ratioR1. IfR0 < 1, the infection-free equilibrium is globally asymptotically
stable; if R1 < 1 < R0, the immunity-inactivated equilibrium is globally asymptotically
stable; if R1 > 1, the immunity-activated equilibrium is globally asymptotically stable
when τ = 0. Besides, we established the existence of Hopf bifurcation at the immunity-
activated equilibrium. By Theorem 5 we found that when the delay varies, the immunity-
activated steady state loses its stability and Hopf bifurcation occurs. That is to say, the
time delay can destabilize the immunity-activated equilibrium and lead to periodic oscil-
lation through Hopf bifurcation. Numerical simulations showed the occurrence of
http://www.journals.vu.lt/nonlinear-analysis
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bifurcating periodic oscillation when the delay passes the critical value. Sensitivity anal-
ysis showed that σ has a great influence on the threshold parameterR0 andR1, which can
provide some suggestions for clinical treatment of HTLV-I related diseases.
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